Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.1 AUD | -0.28% | +6.61% | +15.45% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.45% | 374M | |
+17.97% | 42.77B | |
+19.87% | 22.23B | |
+13.12% | 14.44B | |
+12.19% | 13.05B | |
+35.45% | 11.59B | |
-9.06% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 4.97B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group Widens FY22 Loss